Literature DB >> 31327878

Exploration of the site-specific nature and generalizability of a trimethylammonium salt modification on vancomycin: A-ring derivatives.

Zhi-Chen Wu1, Dale L Boger1.   

Abstract

Vancomycin analogues bearing an A-ring trimethylammonium salt modification were synthesized and their antimicrobial activity against vancomycin-resistant Enterococci (VRE) was evaluated. The modification increased antimicrobial potency and provided the capability to induce bacteria cell membrane permeabilization, but both properties were weaker than that found with our earlier reported similar C-terminus modification. The results provide further insights on the additive effect and generalizability of the structural and site-specific nature of a peripheral quaternary trimethylammonium salt modification of vancomycin.

Entities:  

Keywords:  antibiotic mechanism of action; glycopeptide antibiotics; membrane permeabilization; trimethylammonium salt; vancomycin peripheral modification

Year:  2019        PMID: 31327878      PMCID: PMC6640857          DOI: 10.1016/j.tet.2019.02.008

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  45 in total

Review 1.  Glycopeptide antibiotic resistance.

Authors:  Jeff Pootoolal; John Neu; Gerard D Wright
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.

Authors:  Osamu Yoshida; Tatsuro Yasukata; Yukihito Sumino; Tadashi Munekage; Yukitoshi Narukawa; Yasuhiro Nishitani
Journal:  Bioorg Med Chem Lett       Date:  2002-11-04       Impact factor: 2.823

3.  Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.

Authors:  Casey C McComas; Brendan M Crowley; Dale L Boger
Journal:  J Am Chem Soc       Date:  2003-08-06       Impact factor: 15.419

4.  First and second generation total synthesis of the teicoplanin aglycon.

Authors:  D L Boger; S H Kim; Y Mori; J H Weng; O Rogel; S L Castle; J J McAtee
Journal:  J Am Chem Soc       Date:  2001-03-07       Impact factor: 15.419

Review 5.  Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies.

Authors:  D L Boger
Journal:  Med Res Rev       Date:  2001-09       Impact factor: 12.944

6.  Antibacterial activity of G6-quaternary ammonium derivatives of a lipophilic vancomycin analogue.

Authors:  Timothy A Blizzard; Ronald M Kim; Jerry D Morgan; Jiang Chang; Joyce Kohler; Ruth Kilburn; Kevin Chapman; Milton L Hammond
Journal:  Bioorg Med Chem Lett       Date:  2002-03-25       Impact factor: 2.823

7.  Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate.

Authors:  Lan Chen; Deborah Walker; Binyuan Sun; Yanan Hu; Suzanne Walker; Daniel Kahne
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-24       Impact factor: 11.205

Review 8.  Vancomycin assembly: nature's way.

Authors:  Brian K Hubbard; Christopher T Walsh
Journal:  Angew Chem Int Ed Engl       Date:  2003-02-17       Impact factor: 15.336

Review 9.  The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus.

Authors:  Timothy R Walsh; Robin A Howe
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

10.  Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.

Authors:  M Ge; Z Chen; H R Onishi; J Kohler; L L Silver; R Kerns; S Fukuzawa; C Thompson; D Kahne
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

View more
  6 in total

1.  Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification.

Authors:  Zhi-Chen Wu; Michael D Cameron; Dale L Boger
Journal:  ACS Infect Dis       Date:  2020-07-14       Impact factor: 5.084

2.  Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.

Authors:  Zhi-Chen Wu; Dale L Boger
Journal:  Acc Chem Res       Date:  2020-11-02       Impact factor: 22.384

3.  Thiol- and Disulfide-Containing Vancomycin Derivatives Against Bacterial Resistance and Biofilm Formation.

Authors:  Inga S Shchelik; Karl Gademann
Journal:  ACS Med Chem Lett       Date:  2021-10-18       Impact factor: 4.345

4.  C1-CBP-vancomycin: Impact of a Vancomycin C-Terminus Trimethylammonium Cation on Pharmacological Properties and Insights into Its Newly Introduced Mechanism of Action.

Authors:  Zhi-Chen Wu; Nicholas A Isley; Akinori Okano; William J Weiss; Dale L Boger
Journal:  J Org Chem       Date:  2019-10-31       Impact factor: 4.354

5.  New Molecular Tools for Regulation and Improvement of A40926 Glycopeptide Antibiotic Production in Nonomuraea gerenzanensis ATCC 39727.

Authors:  Oleksandr Yushchuk; Andres Andreo-Vidal; Giorgia Letizia Marcone; Mervyn Bibb; Flavia Marinelli; Elisa Binda
Journal:  Front Microbiol       Date:  2020-01-21       Impact factor: 5.640

Review 6.  Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.

Authors:  Emma van Groesen; Paolo Innocenti; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2022-07-27       Impact factor: 5.578

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.